BBI Solutions – serving the science of diagnostics

BBI Solutions has been serving the global diagnostics industry for over 30 years and is the world’s largest independent producer of immuno-diagnostics reagents.

Our core competencies include a comprehensive suite of reagents with custom development options, lateral flow development, diagnostic and manufacturing services. Leveraging our decades of experience in all stages of diagnostic development for the right solutions the first time.

Your partner from concept to commercialisation

Our connected core competencies and end-to-end services mean that you can partner with one company from initial concept of your assay, through development, sourcing reagents, manufacture and commercialisation of your test.

We develop and manufacture critical components for the diagnostics industry and apply our expertise by delivering solutions that bring critical components together in developing and manufacturing point of care and conventional tests.
Our range of immuno-diagnostics reagents includes human antigens, antibodies, gold nanoparticles and conjugates, enzymes, and serum and plasma products.
With manufacturing sites spanning four continents, we produce world-renowned labels for lateral flow, ELISA assay and biosensors, including our high-quality gold nanoparticles and glucose oxidase.
The acquisition of German-based DIARECT AG in June 2020 established BBI as the leading provider of antigens in the autoimmune and tick-borne IVD markets.
After acquiring IBEX in April 2024, BBI Solutions is now the largest manufacturer of heparinases in the world.

For more information on our comprehensive range of products and services, please see below.

Our Reagents products:

Our Services offering:

To enquire about a particular product or speak to our dedicated customer services team please click here

About Us

BBI Solutions – serving the science of diagnostics

Your partner from concept to commercialisation

Our Reagents products:

Our Services offering:

Newsletter